Journal of Virology, October 2001, p. 9553-9559, Vol. 75, No. 19
Departments of Medicine, Pathology, and
Molecular Microbiology, Washington University School of Medicine,
St. Louis, Missouri 63110
Received 23 April 2001/Accepted 19 June 2001
The human T-cell leukemia virus type 1 (HTLV-1) envelope protein is
required for virus spread. This study further characterizes the role of
the envelope protein in HTLV-1 immortalization. Viruses with single
amino acid substitutions within the SU protein at residue 75, 81, 95, 101, 105, or 195 or with a C-terminal cytoplasmic domain truncation
(CT), as well as an envelope-null (EN) virus, were generated
within an infectious molecular clone, ACH. Transfection of 293T cells
resulted in the release of similar amounts of virus particles from all
of the mutants as determined by p19 enzyme-linked immunosorbent assay
and immunoblot analysis of Gag in cell lysates and supernatants. The
virus particles from all mutants except ACH-101, ACH-CT, and ACH-EN
were infectious for B5 macaque cells in cell-free and cell-to-cell
transmission assays and were capable of immortalizing transfected
CD4+ lymphocytes. These results indicate that HTLV-1 spread
is required for immortalization.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.19.9553-9559.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of Envelope Glycoprotein Mutants
for Human T-Cell Leukemia Virus Type 1 Infectivity and
Immortalization
*
Corresponding author. Mailing address: Box 8069, Washington University, 660 S. Euclid Ave., St. Louis, MO 63110. Phone:
(314) 362-8836. Fax: (314) 747-2797. E-mail:
lratner{at}imgate.wustl.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|